Solanki Sohan Lal, Kumar Pooja P, DeSouza Ashwin, Saklani Avanish P
Department of Anesthesiology, Critical Care and Pain, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Department of Surgical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Indian J Anaesth. 2018 Mar;62(3):225-228. doi: 10.4103/ija.IJA_623_17.
Pressurised intraperitoneal aerosolised chemotherapy (PIPAC) is a new, mostly supportive approach to help patients with advanced peritoneal metastasis to increase the lifespan. It carries occupational hazards to health-care workers and especially anaesthesiologist during the procedure. The aerosolised chemotherapy can also cause chemical peritonitis and organ dysfunction in the perioperative period. In this case report, we present the report of two cases and discuss the perioperative concerns and management related to PIPAC.
腹腔内加压雾化化疗（PIPAC）是一种新型的、主要起支持作用的方法，旨在帮助晚期腹膜转移患者延长生存期。在该治疗过程中，它会给医护人员尤其是麻醉医生带来职业健康风险。雾化化疗在围手术期还可能导致化学性腹膜炎和器官功能障碍。在本病例报告中，我们呈现了两例病例的报告，并讨论了与PIPAC相关的围手术期问题及处理措施。
